FDA Approves FLUTICASONE PROPIONATE ALLERGY RELIEF — GLENMARK THERAPEUTICS INC., USA

# FDA Approves Glenmark Therapeutics' Generic Fluticasone Propionate Nasal Spray The FDA has approved Glenmark Therapeutics Inc.'s abbreviated new drug application for generic fluticasone propionate nasal spray, expanding the competitive landscape for over-the-counter allergy relief and potentially pressuring prices in the nasal corticosteroid market. The approval of this generic alternative to brand-name fluticasone products could capture significant market share from existing branded and generic competitors while offering consumers more affordable options for seasonal and year-round allergy management.